1. Home
  2. INFQ vs HAE Comparison

INFQ vs HAE Comparison

Compare INFQ & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

INFQ

Infleqtion Inc. Common Stock

N/A

Current Price

$9.14

Market Cap

2.9B

Sector

Technology

ML Signal

N/A

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$77.53

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
INFQ
HAE
Founded
2007
1971
Country
United States
United States
Employees
205
N/A
Industry
EDP Services
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.8B
IPO Year
2026
1996

Fundamental Metrics

Financial Performance
Metric
INFQ
HAE
Price
$9.14
$77.53
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$20.00
$84.13
AVG Volume (30 Days)
14.3M
750.3K
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
2.05
Revenue
N/A
$910,373,000.00
Revenue This Year
$25.46
N/A
Revenue Next Year
$25.00
$5.23
P/E Ratio
N/A
$38.30
Revenue Growth
N/A
N/A
52 Week Low
$8.52
$47.32
52 Week High
$21.28
$87.32

Technical Indicators

Market Signals
Indicator
INFQ
HAE
Relative Strength Index (RSI) 33.21 61.05
Support Level $8.54 $71.93
Resistance Level $12.22 $80.90
Average True Range (ATR) 0.91 2.53
MACD -0.35 -0.12
Stochastic Oscillator 6.48 74.30

Price Performance

Historical Comparison
INFQ
HAE

About INFQ Infleqtion Inc. Common Stock

Infleqtion Inc developing and commercializing quantum technology products as part of a full-stack platform, which currently includes offerings such as quantum sensing, quantum computing, and software. Its quantum-enabled solutions are focused on addressing the world's pressing challenges, with technologies actively deployed across some sectors today, including defense and security, artificial intelligence (AI), energy optimization, space and frontier, materials discovery, and cybersecurity.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: